Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OFA: Opioid-Free Anesthesia
NCT03124082Phase 4Unknown
- Sponsor
- University of Parma
- Start
- Jan 2017
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ketamine, Lidocaine Hydrochloride Injection, without epinephrine and clonidine in postoperative pain (2 arms), sponsored by University of Parma. Primary endpoint: Analgesic consumption at 24 hours. Status: unknown.
02
Drugs
ketamineLidocaine Hydrochloride Injection, without epinephrineclonidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03124082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03124082.